| 英語名 | 研究コード | 研究開発ステージ | 会社 | 適応症 | 臨床試験 |
|---|---|---|---|---|---|
| Anti-thyroid stimulating hormone receptor chimeric antigen receptor T cell therapy (Innovative Cellular Therapeutics) | ICTCAT-023 | Phase 2 Clinical | Innovative Cellular Therapeutics Co Ltd | Thyroid Neoplasms | 詳細 |
| ZG-001(Zhigen) | ZG-001(Zhigen); JH-001 | Phase 2 Clinical | Hunan Warner Pharmaceutical Factory Chiral Medicine Co Ltd, Hunan Warrant Pharmaceutical Co Ltd, Shanghai Zhigen Pharmaceutical Technology Co Ltd | Depressive Disorder; Depressive Disorder, Major | 詳細 |
| ICTCAR-051 | ICTCAR-051 | Phase 1 Clinical | Innovative Cellular Therapeutics Co Ltd | Solid tumours; Thyroid Neoplasms | 詳細 |
| KSP-0914 | Phase 1 Clinical | Kissei Pharmaceutical Co Ltd | Graves Disease | 詳細 | |
| GensSci098 | GenSci098; GenSci-098; GensSci-098; GensSci098; GS-098; YB-101 | Phase 1 Clinical | Changchun GeneScience Pharmaceuticals Co Ltd | Goiter; Graves Disease; Graves Ophthalmopathy | 詳細 |
| ICTCAR-TC | ICTCAR-TC | Clinical | Innovative Cellular Therapeutics Co Ltd | Thyroid Neoplasms | 詳細 |
| 英語名 | 研究コード | 研究開発ステージ | 会社 | オリジナル製品名 | 最初に承認をした国 | 最初の適応症 | 最初に承認を受けた会社 | 承認された日付 | 適応症 | 臨床試験 |
|---|---|---|---|---|---|---|---|---|---|---|
| Thyrotropin alfa | rh-TSH; MRrhTSH; rhTSH-M | Approved | Genzyme Corp | Thyrogen | United States | Thyroid Neoplasms | Genzyme Corp | 1998-11-30 | Diagnostic agents; Goiter, Nodular; Thyroid Neoplasms | 詳細 |
| Recombinant human thyrotropin (Zelgen Biosciences) | Approved | Suzhou Zelgen Biosciences Co Ltd | 赛诺璟, 泽速宁 | Mainland China | Thyroid Neoplasms | Suzhou Zelgen Biopharmaceuticals Co Ltd | 2026-01-05 | Thyroid Neoplasms | 詳細 | |
| Recombinant human thyroid stimulating hormone(Smartnuclide) | SNA-001; SNA001; KN040; KN-040 | Approved | Smartnuclide Biopharma | 智舒嘉 | Mainland China | Thyroid Neoplasms | Smartnuclide Biopharma | 2024-04-02 | Thyroid Neoplasms | 詳細 |